M&A Deal Summary

Medtronic Acquires EOFlow

On May 25, 2023, Medtronic acquired medical products company EOFlow

Acquisition Highlights
  • This is Medtronic’s 52nd transaction in the Medical Products sector.
  • This is Medtronic’s 1st transaction in South Korea.

M&A Deal Summary
Date 2023-05-25
Target EOFlow
Sector Medical Products
Buyer(s) Medtronic
Deal Type Add-on Acquisition
Advisor(s) Goldman Sachs (Financial)
Bae, Kim, & Lee (Legal)

Target

EOFlow

Seongnam, South Korea
EOFlow is a medical device company. EOFlow's flagship product is the EOPatch® device, a wearable insulin patch pump that provides continuous insulin delivery for people with diabetes. EOFlow was founded in 2011 and is based in Seongnam, South Korea.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Medtronic

Dublin, Ireland
Category Company
Founded 1949
Sector Medical Products
Employees95,000
Revenue 32.4B USD (2024)
DESCRIPTION
Medtronic's operational headquarters in Fridley, Minnesota.
Medtronic's operational headquarters in Fridley, Minnesota.

Medtronic is a global medical technology company whose products aim to alleviate pain, restore health, and extend life. It serves hospitals, physicians, clinicians, and patients in approximately 160 countries worldwide. Medtronic was founded in 1949 and is based in Dublin, Ireland with its operational headquarters in Fridley, Minnesota.

DEAL STATS #
Overall 59 of 59
Sector (Medical Products) 52 of 52
Type (Add-on Acquisition) 57 of 57
Country (South Korea) 1 of 1
Year (2023) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-01-10 Affera

Newton, Massachusetts, United States

Affera is a medical technology company dedicated to delivering unrivaled innovative solutions to address the rapidly growing demands for cardiac arrhythmia treatment. Affera is developing a comprehensive integrated platform to efficiently deliver durable therapy for a broad set of cardiac arrhythmia patients. Affera is based in Newton, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-08-27 Medtronic - Paceart Optima System

Dublin, Ireland

Medtronic's Paceart Optima System provides on-premises cardiac workflow solutions.

Sell -
Mergr

Product

Company

Legal